We are live on ! Find out more
VNRX icon

VolitionRx Ltd
VNRX

19 hedge funds and large institutions have $12.3M invested in VolitionRx Ltd in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

12% more funds holding

Funds holding: 17 → 19 (+2)

0.05% less ownership

Funds ownership: 0.93% → 0.88% (-0.05%)

29% less capital invested

Capital invested by funds: $17.4M → $12.3M (-$5.04M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
19
Holders Change
+2
Holders Change %
+11.76%
% of All Funds
0.47%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
3
Increased
5
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LIM
Lagoda Investment Management
New York
+$590K
2
LCM
Leisure Capital Management
California
+$215K
3
TRCT
Tower Research Capital (TRC)
New York
+$16.5K
4
AG
Advisor Group
Arizona
+$11.7K
5
Morgan Stanley
Morgan Stanley
New York
+$7.34K

Top Sellers

Rank Fund Capital Flow
1
SCA
Southpoint Capital Advisors
New York
-$1.55M
2
UBS Group
UBS Group
Switzerland
-$7.81K
3
IP
Intellectus Partners
California
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
LIM
1
Lagoda Investment Management
New York
$8.83M +$590K +10,053 +6%
KCM
2
Knoll Capital Management
Florida
$1.24M – – –
SCA
3
Southpoint Capital Advisors
New York
$698K -$1.55M -26,326 -66%
Vanguard Group
4
Vanguard Group
Pennsylvania
$540K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$265K – – –
LCM
6
Leisure Capital Management
California
$193K +$215K +3,662 New
Morgan Stanley
7
Morgan Stanley
New York
$161K +$7.34K +125 +4%
Bank of New York Mellon
8
Bank of New York Mellon
New York
$80K – – –
Northern Trust
9
Northern Trust
Illinois
$60K – – –
GBA
10
Garrison Bradford & Associates
New York
$41K – – –
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
$37K – – –
Creative Planning
12
Creative Planning
Kansas
$35K – – –
AG
13
Advisor Group
Arizona
$30K +$11.7K +200 +53%
BlackRock
14
BlackRock
New York
$29K +$1.17K +20 +4%
Bessemer Group
15
Bessemer Group
New Jersey
$26K – – –
TRCT
16
Tower Research Capital (TRC)
New York
$18K +$16.5K +281 +461%
RE
17
RBC Europe
United Kingdom
$17.3K +$19.3K +329 New
UBS Group
18
UBS Group
Switzerland
$7K -$7.81K -133 -50%
Citigroup
19
Citigroup
New York
$4K +$4.4K +75 New
IP
20
Intellectus Partners
California
– -$1K -14 Closed

VNRX Hedge Fund Activity: Q3 2017 in Review

19 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q3 2017, worth a combined $12.3M — down 29% from $17.4M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new VNRX positions and 1 closed out — a net gain of 2 holders — while 5 added to existing stakes and 2 trimmed.

The largest buyer was Lagoda Investment Management, adding an estimated $590K. The largest seller was Southpoint Capital Advisors, cutting an estimated $1.55M.

  • 19 institutional investors held VolitionRx Ltd (VNRX) as of Q3 2017, up from 17 in Q2 2017.
  • Funds reported $12.3M of VolitionRx Ltd stock for Q3 2017, down 29% quarter-over-quarter.
  • 3 funds opened new VolitionRx Ltd positions in Q3 2017 and 1 closed out, a net change of +2 holders.
  • The largest VolitionRx Ltd buyer in Q3 2017 was Lagoda Investment Management, an estimated $590K added.
  • The largest VolitionRx Ltd seller in Q3 2017 was Southpoint Capital Advisors, an estimated $1.55M sold.

Based on aggregated 13F filings for Q3 2017.